Laboratory of Molecular Neurodegeneration, Saint Petersburg State Polytechnical University Saint Petersburg, Russia.
Front Mol Neurosci. 2013 Sep 18;6:29. doi: 10.3389/fnmol.2013.00029. eCollection 2013.
Alzheimer disease (AD) is a major threat of twenty-first century that is responsible for the majority of dementia in the elderly. Development of effective AD-preventing therapies are the top priority tasks for neuroscience research. Amyloid hypothesis of AD is a dominant idea in the field, but so far all amyloid-targeting therapies have failed in clinical trials. In addition to amyloid accumulation, there are consistent reports of abnormal calcium signaling in AD neurons. AD neurons exhibit enhanced intracellular calcium (Ca(2) (+)) liberation from the endoplasmic reticulum (ER) and reduced store-operated Ca(2) (+) entry (SOC). These changes occur primarily as a result of ER Ca(2) (+) overload. We argue that normalization of intracellular Ca(2) (+) homeostasis could be a strategy for development of effective disease-modifying therapies. The current review summarizes recent data about changes in ER Ca(2) (+) signaling in AD. Ca(2) (+) channels that are discussed in the current review include: inositol trisphosphate receptors, ryanodine receptors, presenilins as ER Ca(2) (+) leak channels, and neuronal SOC channels. We discuss how function of these channels is altered in AD and how important are resulting Ca(2) (+) signaling changes for AD pathogenesis.
阿尔茨海默病(AD)是 21 世纪的主要威胁,是导致老年人痴呆的主要原因。开发有效的 AD 预防疗法是神经科学研究的首要任务。AD 的淀粉样蛋白假说在该领域占据主导地位,但迄今为止,所有针对淀粉样蛋白的治疗方法在临床试验中均告失败。除了淀粉样蛋白的积累外,AD 神经元中还存在一致的异常钙信号报告。AD 神经元表现出增强的内质网(ER)内细胞钙(Ca(2) (+))释放和减少的储存操作钙(SOC)进入。这些变化主要是由于 ER Ca(2) (+)过载而发生的。我们认为,细胞内 Ca(2) (+)稳态的正常化可能是开发有效疾病修饰疗法的一种策略。目前的综述总结了 AD 中 ER Ca(2) (+)信号变化的最新数据。目前综述中讨论的 Ca(2) (+)通道包括:三磷酸肌醇受体、兰尼碱受体、作为 ER Ca(2) (+)泄漏通道的早老素,以及神经元 SOC 通道。我们讨论了这些通道的功能在 AD 中是如何改变的,以及由此产生的 Ca(2) (+)信号变化对 AD 发病机制的重要性。